[Clinical studies on the liver-protective effect of 4-amino-5-imidazole carboxamide and orotic acid].
D000620:Aminoimidazole Carboxamide / Q000494:pharmacology* / Q000627:therapeutic use; D001219:Aspartate Aminotransferases / Q000378:metabolism; D004359:Drug Therapy, Combination; D006505:Hepatitis / Q000188:drug therapy; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology*; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008099:Liver / Q000187:drug effects* / Q000201:enzymology; D008103:Liver Cirrhosis / Q000188:drug therapy; D008107:Liver Diseases / Q000188:drug therapy*; D009963:Orotic Acid / Q000494:pharmacology* / Q000627:therapeutic use; D012709:Serum Albumin / Q000378:metabolism; D005719:gamma-Globulins / Q000378:metabolism
D007093:Imidazoles; D012709:Serum Albumin; D005719:gamma-Globulins; D000620:Aminoimidazole Carboxamide; D009963:Orotic Acid; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases
Klinische Untersuchungen zur Leberschutzwirkung von 5-Amino-5-Imidazolkarboxamid und Orotsäure.